The naturally occurring psychedelic compound psilocybin can significantly reduce symptoms of depression, according to data from the largest study of its kind ever conducted. David Buzzard – media-centre.ca/Getty Images LONDON – The naturally occurring psychedelic compound psilocybin can significantly reduce the symptoms of depression, according to data from the largest study of its kind ever…

Clubholding Humana (HUM) reported a mixed but solid third quarter ahead of the opening bell on Wednesday. The early optimism for 2023 also supported our bullish view on the health insurer’s stock. Revenue rose 9% year over year to $22.75 billion, slightly below estimates of $22.76 billion, and adjusted earnings per share rose 42% to…

Eli Lilly (LLY) CEO David Ricks expressed optimism on the drugmaker’s innovation pipeline on Tuesday, a stance we share despite Club Holding’s cluttered earnings report released earlier in the day. “The underlying fundamentals of the business are really strong,” Ricks said in a CNBC interview with Jim Cramer. “Seventy percent of our sales are relatively…

Johnson & Johnson’s (JNJ) $16.6 billion deal to buy heart pump maker Abiomed (ABMD) will boost its pharmaceutical and medical device businesses before J&J plans to spin off its consumer division into a separate company. The acquisition of Abiomed is expected to be completed by the end of the first quarter of 2023. The spin-off…

A woman receives a dose of a coronavirus disease (COVID-19) vaccine during the coronavirus pandemic at a sports stadium in Vina del Mar, Chile, April 22, 2021. Rodrigo Garrido | Reuters Long Covid is more common in women than men, according to federal data. According to data from the US Census Bureau and National Center…

Every weekday, the CNBC Investing Club hosts a “Morning Meeting” live stream with Jim Cramer at 10:20 am ET. Here’s a recap of Monday’s key moments. Health Care & Staples Leads Market Quick Mentions: META, DIS, SBUX 1. Health Care & Consumer Staples Leads Stocks rose on Monday, with health care & staples stocks taking…

Ivermectin tablets were arranged in Jakarta, Indonesia on Thursday September 2nd, 2021. Dimas Ardian | Bloomberg | Getty Images Ivermectin, a drug once touted by conservatives as a treatment for Covid, does not significantly improve recovery time for people with mild to moderate cases, according to a large clinical study published in a peer-reviewed journal.…

The new COVID-19 booster with protection for Omicron at AltaMed Health Services in South Gate on Thursday October 6, 2022. Sarah Reingewirtz MediaNews Group | Los Angeles Daily News via Getty Images Two studies raise doubts as to whether the new omicron BA.5 booster will really offer better protection against Covid than the first-generation vaccine.…

The Food and Drug Administration said two studies this week showed the new Omicron boosters weren’t much better than the old shots, too small to draw any real conclusions. Scientists from Columbia and Harvard found in two independent studies that the new booster shots and the old omicron BA.5 shots worked essentially the same, raising…

According to data from the Centers for Disease Control and Prevention, two Omicron subvariants that are resistant to key antibody treatments are on the rise in the United States. Subvariants BQ.1 and BQ.1.1 now account for 27% of infections in the US, a significant increase from the previous week when they accounted for about 16%…